146 related articles for article (PubMed ID: 19729283)
41. Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis.
Norman RM; Malla AK; Manchanda R
Schizophr Res; 2007 Sep; 95(1-3):111-4. PubMed ID: 17628442
[TBL] [Abstract][Full Text] [Related]
42. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
[TBL] [Abstract][Full Text] [Related]
43. Remission and recovery during the first outpatient year of the early course of schizophrenia.
Ventura J; Subotnik KL; Guzik LH; Hellemann GS; Gitlin MJ; Wood RC; Nuechterlein KH
Schizophr Res; 2011 Oct; 132(1):18-23. PubMed ID: 21764563
[TBL] [Abstract][Full Text] [Related]
44. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
45. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
Stahl SM; Malla A; Newcomer JW; Potkin SG; Weiden PJ; Harvey PD; Loebel A; Watsky E; Siu CO; Romano S
J Clin Psychopharmacol; 2010 Aug; 30(4):425-30. PubMed ID: 20571437
[TBL] [Abstract][Full Text] [Related]
46. Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
Simonsen C; Faerden A; Romm KL; Berg AO; Bjella T; Sundet K; Ueland T; Andreassen O; Melle I
Psychiatry Res; 2017 Aug; 254():118-125. PubMed ID: 28460281
[TBL] [Abstract][Full Text] [Related]
47. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study.
Chang WC; Tang JY; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
Psychiatry Res; 2013 Oct; 209(3):353-60. PubMed ID: 23473654
[TBL] [Abstract][Full Text] [Related]
48. Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.
Wang J; Hirayasu Y; Hokama H; Tanaka S; Kondo T; Zhang M; Xiao Z
Psychiatry Clin Neurosci; 2005 Apr; 59(2):209-14. PubMed ID: 15823170
[TBL] [Abstract][Full Text] [Related]
49. Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study.
Crespo-Facorro B; de la Foz VO; Ayesa-Arriola R; Pérez-Iglesias R; Mata I; Suarez-Pinilla P; Tabares-Seisdedos R; Vázquez-Barquero JL
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():162-7. PubMed ID: 23435091
[TBL] [Abstract][Full Text] [Related]
50. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
Hofer A; Rettenbacher MA; Widschwendter CG; Kemmler G; Hummer M; Fleischhacker WW
Eur Arch Psychiatry Clin Neurosci; 2006 Jun; 256(4):246-55. PubMed ID: 16311896
[TBL] [Abstract][Full Text] [Related]
51. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.
Fervaha G; Foussias G; Agid O; Remington G
Schizophr Res; 2015 Aug; 166(1-3):9-16. PubMed ID: 25982811
[TBL] [Abstract][Full Text] [Related]
52. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.
Emsley R; Rabinowitz J; Medori R;
Schizophr Res; 2007 Jan; 89(1-3):129-39. PubMed ID: 17095194
[TBL] [Abstract][Full Text] [Related]
53. Short-term remission in schizophrenia as a combination of several outcome measures.
Stratta P; Rossi A
Psychiatry Res; 2013 Oct; 209(3):401-5. PubMed ID: 23684054
[TBL] [Abstract][Full Text] [Related]
54. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
55. One year outcome in first episode schizophrenia. Predictors of relapse.
Uçok A; Polat A; Cakir S; Genç A
Eur Arch Psychiatry Clin Neurosci; 2006 Feb; 256(1):37-43. PubMed ID: 16010602
[TBL] [Abstract][Full Text] [Related]
56. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
57. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
[TBL] [Abstract][Full Text] [Related]
58. [Quality of life in patients with schizophrenia: a study of 100 cases].
Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
[TBL] [Abstract][Full Text] [Related]
60. [Recovery and remission in schizophrenia. Results from a naturalistic 2-year follow-up inpatient study].
Wolter A; Preuss U; Krischke N; Wong JW; Langosch JM; Zimmermann J
Fortschr Neurol Psychiatr; 2010 Aug; 78(8):468-74. PubMed ID: 20694939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
